Neuro-restoration spinal cord injury sales will expand through 2036, with complete injury at 62.0% of the injury severity category, adult at 58.2% of patient age group demand and neurorehabilitation hospitals at 53.5% of end user sales in 2026. The market is projected to record a 5.6% CAGR between 2026 and 2036.